Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Personal Products Industry Analysis

UpdatedMay 30, 2026
DataAggregated Company Financials
Companies109
  • 7D0.4%
  • 3M-14.8%
  • 1Y-18.3%
  • YTD-10.9%

In the last week, Personal Products has been flat. Unfortunately though, the industry is down 18% over the past 12 months. Earnings are forecast to grow by 34% annually.

Industry Valuation and Performance

Has the U.S. Personal Products Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 30 May 2026US$82.8bUS$48.4bUS$758.2m17.3x109.2x1.7x
Mon, 27 Apr 2026US$78.8bUS$48.1bUS$614.7m22.8x128.3x1.6x
Wed, 25 Mar 2026US$78.8bUS$48.2bUS$678.5m21.4x116.1x1.6x
Fri, 20 Feb 2026US$95.9bUS$48.1bUS$858.3m22.7x111.7x2x
Sun, 18 Jan 2026US$94.2bUS$47.6bUS$350.2m22.5x269.1x2x
Tue, 16 Dec 2025US$90.0bUS$47.6bUS$351.1m23x256.3x1.9x
Thu, 13 Nov 2025US$84.2bUS$47.5bUS$492.4m21x171x1.8x
Sat, 11 Oct 2025US$92.6bUS$47.7bUS$307.9m20.5x300.8x1.9x
Mon, 08 Sep 2025US$96.3bUS$47.6bUS$304.2m22.3x316.6x2x
Wed, 06 Aug 2025US$102.7bUS$48.0bUS$104.6m21x981.4x2.1x
Fri, 04 Jul 2025US$101.5bUS$48.0bUS$109.4m18.9x927.7x2.1x
Sun, 01 Jun 2025US$97.7bUS$48.0bUS$128.5m22.2x760.5x2x
Tue, 29 Apr 2025US$86.8bUS$48.7bUS$549.9m21.1x157.9x1.8x
Thu, 27 Mar 2025US$90.4bUS$48.7bUS$451.7m27.4x200.2x1.9x
Sat, 22 Feb 2025US$95.1bUS$48.9bUS$313.7m26.7x303x1.9x
Mon, 20 Jan 2025US$97.9bUS$49.3bUS$1.5b26.8x66.4x2x
Wed, 18 Dec 2024US$102.8bUS$49.3bUS$1.5b28.4x69.6x2.1x
Fri, 15 Nov 2024US$97.1bUS$49.3bUS$1.5b27.8x66x2x
Sun, 13 Oct 2024US$106.9bUS$49.5bUS$1.6b26.6x66.1x2.2x
Tue, 10 Sep 2024US$107.1bUS$49.5bUS$1.6b20.5x65.4x2.2x
Thu, 08 Aug 2024US$108.9bUS$48.7bUS$2.1b23.4x52.9x2.2x
Sat, 06 Jul 2024US$114.4bUS$49.0bUS$2.4b20.7x47.2x2.3x
Mon, 03 Jun 2024US$116.8bUS$49.0bUS$2.4b21.8x48.2x2.4x
Wed, 01 May 2024US$123.5bUS$48.6bUS$2.5b24.2x49.3x2.5x
Fri, 29 Mar 2024US$133.2bUS$48.8bUS$2.5b25.9x53.5x2.7x
Sun, 25 Feb 2024US$130.4bUS$49.0bUS$2.5b29.2x52.5x2.7x
Tue, 23 Jan 2024US$123.8bUS$50.1bUS$2.6b27.1x48.5x2.5x
Thu, 21 Dec 2023US$131.1bUS$49.9bUS$2.6b24.7x49.8x2.6x
Sat, 18 Nov 2023US$112.0bUS$50.0bUS$2.6b21.9x43x2.2x
Mon, 16 Oct 2023US$115.4bUS$50.0bUS$3.3b23.7x35.2x2.3x
Wed, 13 Sep 2023US$131.3bUS$50.0bUS$3.3b19.7x40.1x2.6x
Fri, 11 Aug 2023US$141.4bUS$49.7bUS$3.1b20.2x46.2x2.8x
Sun, 09 Jul 2023US$150.1bUS$49.3bUS$3.1b22x47.9x3x
Tue, 06 Jun 2023US$147.4bUS$49.3bUS$3.1b21.7x47.1x3x
Price to Earnings Ratio

47.1x


Total Market Cap: US$147.4bTotal Earnings: US$3.1bTotal Revenue: US$49.3bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Personal Products Industry Price to Earnings3Y Average 170.8x202420252026
Current Industry PE
  • Investors are pessimistic on the American Personal Products industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 109x which is lower than its 3-year average PE of 171x.
  • The 3-year average PS ratio of 2.2x is higher than the industry's current PS ratio of 1.7x.
Past Earnings Growth
  • The earnings for companies in the Personal Products industry have declined 38% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Consumer Staples industry?

US Market1.47%
Consumer Staples-2.70%
Personal Products0.37%
Personal Products0.37%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
EL Estée Lauder CompaniesUS$88.950.7%
+US$227.9m		32.9%PS2.2x
ELF e.l.f. BeautyUS$56.005.9%
+US$184.3m		-50.2%PE126.5x
COTY CotyUS$2.134.9%
+US$88.0m		-56.8%PS0.3x
ODD Oddity TechUS$13.519.7%
+US$67.4m		-81.8%PE6.9x
IPAR InterparfumsUS$94.371.9%
+US$55.7m		-30.7%PE17.9x

Latest News

USNA
US$18.30
USANA Health Sciences
7D
-2.3%
1Y
-38.7%
ELF
US$56.00
e.l.f. Beauty
7D
5.9%
1Y
-50.2%
YSG
US$3.15
Yatsen Holding
7D
21.6%
1Y
-42.8%
LFVN
US$7.87
LifeVantage
7D
40.3%
1Y
-39.7%
NATR
US$21.28
Nature's Sunshine Products
7D
-2.6%
1Y
37.6%
HLF
US$11.96
Herbalife
7D
-3.8%
1Y
53.1%
EL
US$88.95
Estée Lauder Companies
7D
0.7%
1Y
32.9%
KVUE
US$17.28
Kenvue
7D
-1.4%
1Y
-27.6%
Narrative Update • May 25

KVUE: Future Returns Will Reflect Legal Outcomes And Balanced Earnings Expectations

Analysts have trimmed their average price target on Kenvue by about $0.31 to $19.27 as they refresh models following recent target adjustments and updated assumptions for growth, margins, discount rate, and future P/E multiples. Analyst Commentary Recent target moves around Kenvue reflect a mix of caution and selective optimism, with some analysts trimming price targets while others are willing to nudge them higher after updating models following the latest quarterly report.
BRBR
US$8.36
BellRing Brands
7D
-6.2%
1Y
-86.7%
COTY
US$2.13
Coty
7D
4.9%
1Y
-56.8%
NUS
US$5.79
Nu Skin Enterprises
7D
-2.4%
1Y
-32.9%
Analysis Article • May 18

Nu Skin Enterprises' (NYSE:NUS) Profits May Not Reveal Underlying Issues

The market shrugged off Nu Skin Enterprises, Inc.'s ( NYSE:NUS ) solid earnings report. We did some digging and believe...
WALD
US$1.23
Waldencast
7D
-5.4%
1Y
-54.3%
ODD
US$13.51
Oddity Tech
7D
9.7%
1Y
-81.8%
Narrative Update • May 16

ODD: Ad Platform Reset And Buybacks Will Support Future Confidence Rebuild

Oddity Tech's analyst price targets have been sharply reduced, with cuts ranging from about $4 at several firms to as much as $40 to $48 at others. Analysts cited weaker near term guidance, higher customer acquisition costs tied to advertising platform changes, and reduced visibility on sales and profitability trends.
UPXI
US$1.19
Upexi
7D
-11.2%
1Y
-88.8%
NAGE
US$3.86
Niagen Bioscience
7D
5.5%
1Y
-64.3%
Narrative Update • May 14

NAGE: Core Demand And Injectables Will Drive Future Upside Potential

Niagen Bioscience's analyst price target has shifted from $13.60 to $12.60, as analysts adjust their models to slightly lower revenue growth, profit margin, and fair value assumptions while still highlighting ongoing demand in the core business and potential upside from the injectable segment. Analyst Commentary Recent research updates show a consistent pattern of price target reductions, with the latest move taking the blended target to US$12.60.
IPAR
US$94.37
Interparfums
7D
1.9%
1Y
-30.7%